Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 28, 2020
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
[ Tue, Jul 28th 2020
] - WOPRAI
Mon, July 27, 2020
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
Nathan Rich Initiated (TEVA) at Hold and Held Target at $12 on, Jul 27th, 2020
Nathan Rich of Goldman Sachs, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $12 on, Jul 27th, 2020.
Nathan has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Amsellem of "Piper Sandler" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 15th, 2020
These are the ratings of the 3 analyists that currently disagree with Nathan
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $15 on, Monday, May 11th, 2020
- Jason Gerberry of "B of A Securities" Reiterated at Sell with Increased Target to $8 on, Friday, May 8th, 2020
- David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $8 on, Thursday, April 2nd, 2020
